Buscopan

BACKGROUND Hyoscine N-butyl bromide (HBB) acts by inhibiting cholinergic transmission in the abdomino-pelvic parasympathetic… (More)

OBJECTIVE To evaluate the efficacy and safety of hyoscine-N-butyl bromide (Buscopan) suppositories in the active phase of labour… (More)

PURPOSE To assess primarily the feasibility of magnetic resonance imaging (MRI) as a tool to monitor small bowel peristaltic… (More)

The aim of this study was to examine the efficacy of IV Buscopan as a muscle relaxant in CT colonography in terms of colonic… (More)

AIM To evaluate the efficacy of peppermint oil in barium as a spasmolytic agent during a double-contrast barium enema (DCBE… (More)

We investigated the effect of Buscopan 20 mg, given at the end of surgery, on analgesic requirements in 44 ASA I and II patients… (More)

PURPOSE To compare the spasmolytic effect of glucagon and buscopan in double contrast barium enema examination. PATIENTS AND… (More)

A double-blind, randomized parallel group trial comparison involving 712 patients with irritable bowel syndrome was performed… (More)

This prospective study was undertaken to establish whether Buscopan (hyosine butyl bromide) interferes with the detection of a… (More)

The number of intravenous injections of hyoscine-N-butylbromide (Buscopan) or glucagon required to maintain relaxation of the… (More)